Skip to main content
OpenTrials
Completed

NCT Number: NCT05798325

Feasibility, Validation and Application of Digital Tools for the Follow-up of Neuromuscular Patient Mobility in Daily Living

The low prevalence of rare diseases hinders the design of clinical studies with sufficient statistical power to demonstrate the efficacy of new drugs. This can only be achieved by setting up international multicentre studies, which is challenging due to a lack of objective, universal outcome measures that generate high-quality, reproducible data. One of the hurdles in attaining universal outcome measures for clinical trials is the difficulty to capture and distinguish ambulatory from non-ambulatory, autonomous and assistive or involuntary movements. This makes a trial assessing the ambulatory phase very challenging at this moment. Excluding many participants from trials and many patients from access to medication.

Integration and validation of the technology in trials, research and patients' lives is essential in overcoming this hurdle. For example, in dystrophinopathies separate outcome measures exist for ambulant and non-ambulant participants, but the relation between these outcome measures or a transitional outcome measure/end point is largely missing.

Following an exhaustive literature review, several tools have been selected to remotely follow various symptoms of neuromuscular patients including weakness, pain, fatigue, cognitive defects, motor impairments (including loss of dexterity, ataxia...), metabolic, respiratory and cardiac troubles, contractures, tremor, falls, hypo or hypersomnia... The toolbox includes common measures for all patients but may include additional measures specific to the patient's symptoms (hence in turn to the patients' disease).

The measurements are designed to not be invasive, intrusive or burdensome for the patient.

DT4RD is going to leverage state-of-the art technology, clinical rating scales and psychometric/data analysis to deliver fit for purpose remote clinical assessments of mobility to ensure maximum patient benefit, specifically:

* Compare face to face clinical data collected in hospital with Patient Generated Data recorded remotely * Examine how sensors can enhance measurement potentially at home and during clinical visits * Promote a clear focus on user centered design and the integration of technology * Use reliability and validity analyses to equate any common measures (those with the same or a similar construct) * Demonstrate a proof-of-concept model into which different measures can be interchangeable

Completed

Looking for future studies?

Notify Me

Key information

Age range

12 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Association Institut de Myologie, Paris, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged between 12 and 60 years
  • Patients with a genetically confirmed/molecular-proven neuromuscular or neurometabolic disease*
  • Patients experiencing walking difficulties in the home and at high risk of limiting participation and walking outside of the home.
  • Written informed consent
  • Able to comply with all protocol requirements, including video recording
  • Affiliated to or beneficiary of a social security scheme (for France)

Exclusion criteria

  • Patients with undefined diagnosis or any diagnosis other than neuromuscular or neurometabolic disease
  • Patient walking 10m in less than 10s
  • Guardianship/trusteeship
  • Pregnant or nursing women
  • Patients having relevant concomitant pathologies that, in the appreciation of the investigator could interfere with protocol compliance
  • Patients not being affiliated with local social security (for France)

Treatment and study plan

2MWT

Other

Two minutes walk tests.

Other names: Two minutes walk tests

MFM32

Other

Motor Function Measurement (MFM) is a quantitative scale created to measure global motor functional abilities in a person with neuromuscular disease.

Other names: Muscle Motor Function 32

MyoGrip

Other

The MyoGrip is a dynamometer for measuring grip strength.

QOL-gNMD

Other

The "Quality of Life in genetic Neuromuscular Disease" questionnaire (QoL-gNMD) is a patient reported outcome measure (PROM) tool specifically designed for patients with a lowly progressive neuromuscular disease with genetically predominant muscular damage

Spirometry

Diagnostic Test

Forced vital capacity (FVC), peak expiratory flow (PEF) and forced expiratory volume in 1 second (FEV1) will be measured in the hospital with the local hospital device (e.g. Vitalograph) under the supervision of the clinical evaluator, and at home with a portable device.

Other names: Spirobank Smart

Acceleromerty

Device

The Links sensor system is a measuring device and consists of the Links Pods and the Links Hub. The Links pods contain an accelerometer, gyroscope and magnetometer to measure position relative to a global reference frame.

Other names: Links sensor system

10mWT

Other

10 meters walking Test.

PUL

Other

The Performance of the Upper Limb (PUL) is a functional scale specifically designed for assessing upper limb function in Duchenne muscular dystrophy.

Other names: Performance of Upper Limb

NSAA

Other

The North Star Ambulatory Assessment (NSAA) is a 17-item rating scale that is used to measure functional motor abilities in ambulant children with Duchenne Muscular Dystrophy.

Other names: North Star Ambulatory Assessment

NSAD

Other

The NSAD was developed to measure motor performance in ambulant and non-ambulant subjects as part of the clinical outcome study of dysferlinopathy.

Other names: North Star Assessment for limb-girdle type muscular dystrophies

TANS

Other

This scale is derived from the North Star Ambulatory Assessment and several items from the Egan Klassifikation Scale (EK2).

Other names: Transition Assessment North Star

MyoPinch

Other

The MyoPinch is a high-precision dynamometer that allows the evaluation of key pinch strength.

MyoQuad

Other

The MyoQuad is a high-precision dynamometer that allows the evaluation of knee extension strength.

ACTIVLIM

Other

Activity limitations, as measured by ACTIVLIM, is defined as the difficulties a patient may have in executing daily activities, whatever the strategies involved.

PREM

Other

This questionnaire is made up of simple questions relating to the assessments and assessment tools that were used during the study.

Other names: Patient Reported Experience Measures

SF-MPQ

Other

The main component of the SF-MPQ consists of 15 descriptors (11 sensories; 4 affective) which are rated on an intensity scale as 0 = none, 1 = mild, 2 = moderate or 3 = severe.

Other names: Modified Short-form McGill Pain Questionnaire

FSS

Other

The Fatigue Severity Scale is used to assess the severity of fatigue and its impact on daily living. The patient responds on a Likert-type scale ranging from 1 to 7.

Other names: Fatigue Severity Scale

IPAQ

Other

This questionnaire assesses overall physical activity and the level of sedentary lifestyle during the last seven days.

Other names: International Physical Activity Questionnaire

Rang of motion

Other

The EasyAngle® is a digital goniometer improving long established goniometric functionality with rotation, inclination, and scoliosis measurement capabilities.

Other names: EasyAngle

Goniometry

Device

The Links sensor system is a measuring device and consists of the Links Pods and the Links Hub. The Links pods contain an accelerometer, gyroscope and magnetometer to measure position relative to a global reference frame.

Other names: Links Sensor System goniometers

Video captured monitoring

Other

Once every four weeks, while wearing the Yumen electronic goniometers (Links Sensor System), the patients will be asked to record on video three tasks related to:

  • Upper limbs: hands to head
  • Lower limbs: Sit to stand with or without the help of a person
  • Self-defined important task: A task of the patient's choice, from a list of tasks, representative of his/her motor difficulties or hindrance to autonomy.

Activity Monitoring

Device

Wearable devices (connected watch) will collect health-related data on a 24/7 basis remotely as patients go through their daily routines at home and work.

Other names: Activity assessment and physiological parameters

Primary outcomes

  1. Global home evaluations' attendance

    Time frame: Through study completion, an average of 1 year

    Proportion of home assessments carried out compared to the number of home assessments planned

Secondary outcomes

  1. Compliance with filling out questionnaires at home

    Time frame: Through study completion, an average of 1 year

    Analysis of the proportion of replies to the questionnaires at home

  2. Compliance regarding using of the spirometer at home

    Time frame: Through study completion, an average of 1 year

    Analysis of the proportion of valid spirometry data collected at home

  3. Compliance regarding using of the LINKS sensors device at home

    Time frame: Through study completion, an average of 1 year

    Analysis of the proportion of usable accelerometry data collected at home

  4. Compliance regarding using of the activity sensor at home

    Time frame: Through study completion, an average of 1 year

    Analysis of the proportion of usable data collected at home using the smartwatch

  5. Compliance regarding achievement of video tasks at home

    Time frame: Through study completion, an average of 1 year

    Analysis of the usability of the video tasks performed at home

  6. Correlation of home and hospital spirometer Forced vital capacity measurements

    Time frame: Through study completion, an average of 1 year

    Comparison of Forced vital capacity data collected during home and hospital spirometer measurements

  7. Correlation of home and hospital spirometer peak expiratory flow measurements

    Time frame: Through study completion, an average of 1 year

    Comparison of Peak expiratory flow data collected during home and hospital spirometer measurements

  8. Correlation of home and hospital spirometer forced expiratory volume in 1 second measurements

    Time frame: Through study completion, an average of 1 year

    Comparison of forced expiratory volume in 1 second data collected during home and hospital spirometer measurements

Sponsors and collaborators

Lead sponsor

Institut de Myologie, France

Other

Collaborators

  • Aparito Ltd.

Registry information

Official study title

Feasibility, Validation and Application of Digital Tools for the Follow-up of Neuromuscular Patient

Acronym: DT4RD

Important dates

Study start
2023
Primary completion
2025
Study completion
2025
First posted
Apr 4, 2023
Registry last updated
Jun 29, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.